Exploring Unmet Needs and Attitudes to Skin Self-examination in Melanoma Survivors

Oxford University Hospitals NHS Trust252 enrolled

Overview

This is a prospective, multi-centred cohort study whereby the EUNASS Study questionnaire will be administered electronically to identify needs of melanoma survivors, the extent to which these needs are being met, and identify areas which have the greatest need for development. It will also evaluate behaviour in relation to sun protection and skin self-examination (SSE). It will be a self-completed questionnaire. Qualitative work using semi-structured interviews will explore the needs of melanoma survivors in greater depth, will present examples of potential interventions to improve SSE and explore factors that determine the likelihood of engaging in an intervention which can address unmet needs, such as improving SSE. Taken together, the data will provide the evidence base to inform the development of an intervention to improve SSE, which can subsequently be tested in secondary care services.

Study Type

OBSERVATIONAL

Enrollment

252

Conditions

Melanoma, Stage I Melanoma Stage III Melanoma, Stage II

Interventions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged 18 years or above. * Histological diagnosis of primary cutaneous invasive melanoma (any Breslow thickness) at 3 - 12 months from diagnosis (as most primary treatment will be complete by 3 mths) * American Joint Cancer Committee Version 8 \[2018\] (AJCC V8) Stage I - III melanoma at time of recruitment * Able to complete an electronic questionnaire Exclusion Criteria: * Other current active internal malignancy (i.e. does not include non-melanoma skin cancers) * Inability to independently complete electronic questionnaire * AJCC V8 Stage IV melanoma at time of recruitment * Clinical stage of disease unknown / unconfirmed

Outcomes

Primary Outcomes

Mixed methods: analysis of a) Patient questionnaire responses and b) Semi-structured interviews

Mixed methods analysis - quantitative and qualitative results

Time frame: 2 years